Vanda Pharmaceuticals Inc (VNDA)
Stock-Based Compensation
$4.67M
Quarterly · Period ending: · USD
VNDA Stock-Based Compensation
Latest reported$4.67Mperiod ending
Latest reported$4.67Mperiod ending
VNDA Quarterly Stock-Based Comp ($0.00 → $4.67M)
Quarterly stock-based compensation
High-resolution chart · PNG
VNDA stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 4,670,000 | |
| 2,563,000 | |
| 2,285,000 | |
| 2,112,000 | |
| 2,106,000 | |
| 2,971,000 | |
| 2,863,000 | |
| 2,999,000 | |
| 2,986,000 | |
| 3,584,000 | |
| 3,273,000 | |
| 3,167,000 | |
| 3,249,000 | |
| 4,351,000 | |
| 3,783,000 | |
| 3,888,000 | |
| 3,830,000 | |
| 4,778,000 | |
| 3,774,000 | |
| 3,951,000 | |
| 3,740,000 | |
| 3,909,000 | |
| 3,212,000 | |
| 3,135,000 | |
| 3,069,000 | |
| 3,944,000 | |
| 3,668,000 | |
| 3,407,000 | |
| 3,101,000 | |
| 3,282,000 | |
| 2,922,000 | |
| 2,872,000 | |
| 2,721,000 | |
| 3,151,000 | |
| 2,782,000 | |
| 2,771,000 | |
| 2,656,000 | |
| 2,256,000 | |
| 2,103,000 | |
| 2,100,000 | |
| 2,074,000 | |
| 2,266,000 | |
| 1,887,000 | |
| 2,061,000 | |
| 2,068,000 | |
| 1,945,000 | |
| 1,631,000 | |
| 1,411,000 | |
| 1,443,000 | |
| 1,393,000 | |
| 1,283,000 | |
| 1,539,000 | |
| 830,000 | |
| 952,000 | |
| 923,000 | |
| 576,000 | |
| 1,193,000 | |
| 1,402,000 | |
| 1,318,000 | |
| 1,254,000 | |
| 1,325,000 | |
| 1,604,000 | |
| 1,335,471 | |
| 886,721 | |
| 1,638,986 | |
| 1,120,822 | |
| 2,521,501 | |
| 3,429,360 | |
| 2,970,719 | |
| 2,308,647 | |
| 13,387,789 | |
| 0 | |
| 0 | |
| 0 | |
| 19,622,814 | |
| 0 | |
| 0 | |
| 4,107,972,000 | |
| 6,131,827,000 | |
| 0 | |
| 0 | |
| 1,520,317,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |